Cumberland Pharmaceuticals Inc.: 10-Q filed 2012-08-09
What Cumberland Pharmaceuticals Inc. reported in its quarterly report filed 2012-08-09 (fiscal Q2 2012): 36 published measures, 98 facts as tagged in accession 0001193125-12-347942.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2012-08-09
- Fiscal period
- fiscal Q2 2012
- Accession
- 0001193125-12-347942 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cumberland Pharmaceuticals Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 95,380,596 | USD | |
| At 2011-12-31 | 95,518,316 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 12,166,990 | USD | |
| At 2011-12-31 | 12,683,047 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 83,324,557 | USD | |
| At 2011-12-31 | 82,928,817 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 52,273,392 | USD | |
| At 2011-12-31 | 70,599,146 | USD | |
| At 2011-06-30 | 69,832,030 | USD | |
| At 2010-12-31 | 65,893,970 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 1,744,290 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 2,167,498 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 2,177,619 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 2,898,779 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 3,245,479 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 4,935,347 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 178,886 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 105,838 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -2,661,792 | USD | 182 |
| 2011-01-01 to 2011-06-30 | -845,105 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -18,909,441 | USD | 182 |
| 2011-01-01 to 2011-06-30 | -152,182 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 14,824,160 | USD | |
| At 2011-12-31 | 12,656,662 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 19,771,167 | shares | 91 |
| 2012-01-01 to 2012-06-30 | 19,889,583 | shares | 182 |
| 2011-04-01 to 2011-06-30 | 20,471,621 | shares | 91 |
| 2011-01-01 to 2011-06-30 | 20,458,842 | shares | 181 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 19,996,805 | shares | 91 |
| 2012-01-01 to 2012-06-30 | 20,117,246 | shares | 182 |
| 2011-04-01 to 2011-06-30 | 20,661,719 | shares | 91 |
| 2011-01-01 to 2011-06-30 | 20,719,714 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 0.09 | USD/shares | 91 |
| 2012-01-01 to 2012-06-30 | 0.11 | USD/shares | 182 |
| 2011-04-01 to 2011-06-30 | 0.11 | USD/shares | 91 |
| 2011-01-01 to 2011-06-30 | 0.14 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 0.09 | USD/shares | 91 |
| 2012-01-01 to 2012-06-30 | 0.11 | USD/shares | 182 |
| 2011-04-01 to 2011-06-30 | 0.11 | USD/shares | 91 |
| 2011-01-01 to 2011-06-30 | 0.14 | USD/shares | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 263,031 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 545,059 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 1,436,365 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 1,959,949 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 1,100,253 | USD | |
| At 2011-12-31 | 1,119,339 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 315,344 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 315,513 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 1,939,931 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 2,585,946 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 3,631,857 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 5,039,858 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 86,257,157 | USD | |
| At 2011-12-31 | 87,308,067 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 16,720 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 39,147 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 79,604 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 295,647 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 7,132,066 | USD | |
| At 2011-12-31 | 6,599,948 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 2,936,081 | USD | |
| At 2011-12-31 | 1,513,548 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 7,373,013 | USD | |
| At 2011-12-31 | 7,023,064 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 4,991,612 | USD | |
| At 2011-12-31 | 7,082,890 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 3,562,381 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 1,551,847 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 7,316,606 | USD | |
| At 2011-12-31 | 5,774,694 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 1,553,343 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 2,957,365 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 1,027,048 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 2,036,721 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 19,699,237 | shares | |
| At 2011-12-31 | 20,020,535 | shares |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 83,213,606 | USD | |
| At 2011-12-31 | 82,835,269 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 650,173 | USD | |
| At 2011-12-31 | 67,846 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 1,736,254 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 2,150,095 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 2,168,148 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 2,879,431 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 2,164,098 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 4,429,123 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 2,371,506 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 4,373,510 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 441,199 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 527,301 | USD | 181 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 114,599 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 226,646 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 171,726 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 343,453 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -2,091,278 | USD | 182 |
| 2011-01-01 to 2011-06-30 | -325,760 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 1,541,912 | USD | 182 |
| 2011-01-01 to 2011-06-30 | -230,591 | USD | 181 |
Inspect the source
- Entity
- Cumberland Pharmaceuticals Inc. / CIK 0001087294
- Captured
- 2026-09-20T05:21:29.619Z
- SEC response SHA-256
b37ed2fef35db1cde0c40b2233eb97cf370fc96d41a5c7d61b6a5a76a296e4a0
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001087294.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))